Ty-Jour T1 - 通过右心导管肺动脉抑制评估 - 确实是时序物吗？JF - 欧洲呼吸杂志Jo - Eur Respir J Do - 10.1183 / 13993003 - 1901892-2019 SP - 1901892-2019 SP - 1901892-2019 SP - 1901892-2019 SP - 1901892-2019 SP - 1901892-2019 SP - 1901892-2019 SP - yogeswaran，竞技场AU - RICHTER，Manuel Jonas Au - Sommer，Natascha Au - Ghofrani，Hossein Ardeschir Au - Seeger，Werner Au - Gall，Henning Au - Tello，Khodr Y1 - 2020 / 01/01 UR - //www.qdcxjkg.com/content/early/2020/04/08/1399393003.018/1399393003.018/1399393003.018/1399393003.018/1399393003.018/1399.bstract n2 - 右心导管（RHC）用于肺动脉高压（pH）中的诊断和风险分层[1]。在肺动脉高压（PAH）指南中实施的风险分层方案已在现实队伍中验证[1-5]。但是，没有指定RHC期间测量的定时。我们的旨在调查测量测量时间对RHC参数的影响以及风险分层和诊断的后果。最近被接受欧洲呼吸杂志的出版物。它在汇款和排版的抄本之前在此处发布于其已接受的表单。在这些生产过程完成后，作者已批准所产生的证据，这篇文章将转入最新问题ERJ Online。请打开或下载PDF以查看本文。兴趣博士：Yogeswaran博士在学习期间向Giessen大学报告了非财政支持。感兴趣的Conflict：Richter博士报告德国研究基金会的赠款，非- 在研究中，吉森大学的金融支持;来自拜耳的联合治疗，赠款和个人费用的补助金，个人费用，来自Mundipharma的个人费用，罗氏的个人费用，来自OMT的个人费用，在提交的工作之外。感兴趣：Sommer博士报告了actelion的个人费用，在提交的工作之外。兴趣：GHOFRANI博士在进行研究期间，GIESEN大学的德国研究基金会，非财政支持的赠款报告; personal fees from Bayer, personal fees from Actelion, personal fees from Pfizer, personal fees from Merck, personal fees from GSK, grants and personal fees from Novartis, grants and personal fees from Bayer HealthCare, grants and personal fees from Encysive/Pfizer, grants from Aires, grants from German Research Foundation, grants from Excellence Cluster Cardiopulmonary Research, grants from German Ministry for Education and Research, personal fees from Takeda, outside the submitted work.Conflict of interest: Dr. Seeger reports grants from German Research Foundation, non-financial support from University of Giessen, during the conduct of the study; personal fees from Pfizer, personal fees from Bayer Pharma AG, outside the submitted work.Conflict of interest: Dr. Gall reports grants from German Research Foundation, non-financial support from University of Giessen, during the conduct of the study; personal fees from Actelion, personal fees from AstraZeneca, personal fees from Bayer, personal fees from BMS, personal fees from GSK, personal fees from Janssen-Cilag, personal fees from Lilly, personal fees from MSD, personal fees from Novartis, personal fees from OMT, personal fees from Pfizer, personal fees from United Therapeutics, outside the submitted work.Conflict of interest: Dr. Tello reports grants from German Research Foundation, non-financial support from University of Giessen, during the conduct of the study; personal fees from Actelion, personal fees from Bayer, outside the submitted work. ER -